BioLight Israeli Life Sciences Investments Ltd
Venture Capital
Active
Tel Aviv, Israel
3
8M
3
0.19
1
- Areas of investment
Summary
In 2005 was created BioLight Israeli Life Sciences Investments Ltd, which is appeared as VC. The leading representative office of defined VC is situated in the Tel Aviv. The fund was located in Asia if to be more exact in Israel.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular portfolio startups of the fund, we may highlight Ioptima. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Medical.
The usual cause for the fund is to invest in rounds with 1 partaker.
The high activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Rounds per year
- 0.19
- Investments by industry
- Medical Device (2)
- Health Care (2)
- Eyewear (1)
- Medical (1)
- Laser (1) Show 5 more
- Investments by region
-
- Israel (2)
- United States (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
BELKIN Laser | 21 Jul 2020 | Health Care, Medical Device, Laser | Early Stage Venture | 12M | North District, Israel, Israel |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.